DIN 02434334 — OTEZLA 30 MG
OTEZLA is a tablet of Apremilast marketed by AMGEN CANADA INC. The full Apremilast monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02434334
- Brand name
- OTEZLA
- Active ingredient
- Apremilast
- Strength
- 30 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Phosphodiesterase 4 (PDE4) inhibitor (selective immunosuppressant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Apremilast products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02538180 | APO-APREMILAST | 30 MG | TABLET | APOTEX INC | MARKETED |
| 02524104 | AURO-APREMILAST | 30 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02524120 | AURO-APREMILAST | 30 MG; 20 MG; 10 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02518910 | GLN-APREMILAST | 30 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |
| 02528967 | JAMP APREMILAST | 10 MG; 20 MG; 30 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02528959 | JAMP APREMILAST | 30 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02525747 | MINT-APREMILAST | 30 MG | TABLET | MINT PHARMACEUTICALS INC | DORMANT |
| 02434318 | OTEZLA | 30 MG; 10 MG; 20 MG | TABLET | AMGEN CANADA INC | MARKETED |
| 02521733 | PMS-APREMILAST | 30 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02529092 | SANDOZ APREMILAST | 20 MG; 10 MG; 30 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02529084 | SANDOZ APREMILAST | 30 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |